Published May 19, 2026 | Version v1
Dataset Open

ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN: GLOBAL, SOUTH ASIAN, AND CENTRAL ASIAN PERSPECTIVES

Description

Acute lymphoblastic leukemia (ALL) is the leading childhood cancer worldwide. Over recent decades, survival from pediatric ALL has risen dramatically in highincome countries due to riskadapted combination chemotherapy, robust supportive care, and coordinated clinical trial networks. However, striking disparities persist between and within regions, particularly in South Asia and Central Asia, where late presentation, treatment abandonment, and limited diagnostic and therapeutic capacity remain major obstacles. This review summarizes the global epidemiology and biology of childhood ALL, outlines treatment outcomes and healthsystem constraints, and examines specific challenges and opportunities in South Asia and Central Asia.

Files

1295-1300.pdf

Files (198.5 kB)

Name Size Download all
md5:657215ae322921d00aeaa2b94fa36b77
198.5 kB Preview Download

Additional details

References

  • 1.Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015 Oct 15;373(16):1541–52.
  • 2.Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015 Jan 10;33(27):2938–48.
  • 3.Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524–39.
  • 4.Gupta S, Howard SC, Hunger SP, Antillon FG, Metzger ML, Israels T, et al. Treating childhood cancer in low- and middle-income countries. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: disease control priorities. 3rd ed. Vol. 3. Washington (DC): World Bank; 2015. p. 121–46.
  • 5.Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019 Apr;20(4):483–93.